<unk>  (brand name Monomestro or Monomestrol), also known as diethylstilbestrol monomethyl ether, is a synthetic nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol. It was developed by Wallace & Tiernan Company, patented in 1940, and introduced for medical use in the 1940s, but is now no longer marketed.<unk>  was available both as oral tablets and in oil for intramuscular injection. The drug is gradually demethylated in the body into diethylstilbestrol and hence is a prodrug of diethylstilbestrol.<unk>  is a highly active estrogen, although somewhat less so than diethylstilbestrol, but is longer-lasting in comparison.
Mestilbol
Nafoxidine
Clascoterone
Flupamesone
Epiestriol
Ecallantide
Casimersen
Ridinilazole